[124I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection

Nuclear Medicine and Biology

Volumn 43, Issue 5, 2016, Pages 273-279

  Zhang, Xiaoyan M ^a   Zhang, Halle H ^a   McLeroth, Patrick ^b   Berkowitz, Richard D ^c   Mont, Michael A ^d   Stabin, Michael G ^e   Siegel, Barry A ^f   Alavi, Abass ^g   Barnett, T Marc ^h   Gelb, Jeffrey ^b   Petit, Chantal ^b   Spaltro, John ^b   Cho, Steve Y ⁱ   Pomper, Martin G ^j   Conklin, James J ^k   Bettegowda, Chetan ^l   Saha, Saurabh ^a  

^a BioMed Valley Discoveries Inc   (United States)

^b Dept of Stat and Clin Programming   (United States)

^c Phoenix Clinical Research   (United States)

^d SINAI HOSPITAL OF BALTIMORE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^h Mission Hospital   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k ICON Medical Imaging   (United States)

^l DEPARTMENT OF PATHOLOGY   (United States)

more..

Author keywords

Diagnosis; FIAU; PET CT; Prosthetic joint infection

Indexed keywords

IODINE FIALURIDINE I 124; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; FIALURIDINE; URACIL ARABINOSIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOSIMETRY; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG UPTAKE; DRUG WITHDRAWAL; FEMALE; HIP PROSTHESIS; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INJECTION SITE PAIN; KNEE PROSTHESIS; MALE; PARESTHESIA; PROSPECTIVE STUDY; PROSTHESIS INFECTION; RADIATION DOSE; STOMACH HEMORRHAGE; STOMACH PAIN; STOMACH ULCER; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ARTHROPATHY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; INFECTION; METABOLISM; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROCEDURES; RADIOMETRY; SAFETY; TISSUE DISTRIBUTION;

ADULT; ARABINOFURANOSYLURACIL; FEMALE; HUMANS; JOINT DISEASES; MALE; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; RADIOMETRY; SAFETY; TISSUE DISTRIBUTION;

EID: 84960445318     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2016.01.004     Document Type: Article

References (32)

1. Workgroup Convened by the Musculoskeletal Infection Society New definition for periprosthetic joint infection. J Arthroplast 2011, 26:1136-1138.
2. Zmistowski B., Della Valle C., Bauer T.W., et al. Diagnosis of periprosthetic joint infection. J Orthop Res 2014, 32(Suppl. 1):98-107.
3. Sendi P., Zimmerli W. Diagnosis of periprosthetic joint infections in clinical practice. Int J Artif Organs 2012, 35:913-922.
4. Tetreault M.W., Wetters N.G., Moric M., Gross C.E., Della Valle C.J. Is synovial C-reactive protein a useful marker for periprosthetic joint infection?. Clin Orthop Relat Res 2014, 472:3997-4003.
5. Zmistowski B., Restrepo C., Huang R., Hozack W.J., Parvizi J. Periprosthetic joint infection diagnosis: a complete understanding of white blood cell count and differential. J Arthroplast 2012, 27:1589-1593.
6. Del Arco A., Bertrand M.L. The diagnosis of periprosthetic infection. Open Orthop J 2013, 7:178-183.
7. Choi H.R., Kwon Y.M., Freiberg A.A., Nelson S.B., Malchau H. Periprosthetic joint infection with negative culture results: clinical characteristics and treatment outcome. J Arthroplast 2013, 28:899-903.
8. Janz V., Wassilew G.I., Hasart O., Tohtz S., Perka C. Improvement in the detection rate of PJI in total hip arthroplasty through multiple sonicate fluid cultures. J Orthop Res 2013, 31:2021-2024.
9. Parvizi J., Adeli B., Zmistowski B., Restrepo C., Greenwald A.S. Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am 2012, 94.
10. Müller M., Morawietz L., Hasart O., Strube P., Perka C., Tohtz S. Diagnosis of periprosthetic infection following total hip arthroplasty- evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res 2008, 3:31.
11. Palestro C.J. Nuclear medicine and the failed joint replacement: past, present, and future. World J Radiol 2014, 6:446-458.
12. Glaudemans A.W., Galli F., Pacilio M., Signore A. Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater 2013, 25:61-77.
13. Gemmel F., Van den Wyngaert H., Love C., Welling M.M., Gemmel P., Palestro C.J. Prosthetic joint infections: radionuclide state-of-the-art imaging. Eur J Nucl Med Mol Imaging 2012, 39:892-909.
14. van der Bruggen W., Bleeker-Rovers C.P., Boerman O.C., Gotthardt M., Oyen W.J. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med 2010, 40:3-15.
15. Bettegowda C., Foss C., Cheong I., et al. Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2-fluoro-o -D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A 2005, 102:1145-1150.
16. 124I]FIAU-PET/CT. PLoS One 2007, 2.
17. McAuliffe M.J., Lalonde F.M., McGarry D., et al. Medical image processing, analysis and visualization in clinical research. IEEE Symposium on Computer-Based Medical Systems (CBMS) 2001, 381-386.
18. Foster D.M. Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system. Adv Exp Med Biol 1998, 445:59-78.
19. Stabin M.G., Siegel J.A. Physical models and dose factors for use in internal dose assessment. Health Phys 2003, 85:294-310.
20. Stabin M.G., Sparks R.B., Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005, 46:1023-1027.
21. Roth T.D., Maertz N.A., Parr J.A., Buckwalter K.A., Choplin R.H. CT of the hip prosthesis: appearance of components, fixation, and complications. Radiographics 2012, 32:1089-1107.
22. McKenzie R., Fried M., Sallie R., et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995, 333:1099-1105.
23. Institute of Medicine (US) Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials. Review of the fialuridine (FIAU) clinical trials 1995, National Academies Press (US), Washington, DC. M. FJ, M. Swartz (Eds.).
24. 99mTc-HMPAO-labeled leukocytes. Investig Radiol 1994, 29:443-447.
25. Jones S.C., Alavi A., Christman D., Montanez I., Wolf A.P., Reivich M. The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med 1982, 23:613-617.
26. Arnold W.V., Shirtliff M.E., Stoodley P. Bacterial biofilms and periprosthetic infections. Instr Course Lect 2014, 63:385-391.
27. Parvizi J., Erkocak O.F., Della Valle C.J. Culture-negative periprosthetic joint infection. J Bone Joint Surg Am 2014, 96:430-436.
28. 18F-fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogs. J Nucl Med 2007, 48:655-660.
29. Wang L., Munch-Petersen B., Herrström Sjöberg A., Hellman U., Bergman T., Jörnvall H., et al. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett 1999, 443:170-174.
30. Wang J., Eriksson S. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity. Antimicrob Agents Chemother 1996, 40:1555-1557.
31. Johansson M., Karlsson A. Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J Biol Chem 1997, 272(13):8454-8458.
32. Fu D.X., Tanhehco Y.C., Chen J., et al. Virus-associated tumor imaging by induction of viral gene expression. Clin Cancer Res 2007, 13:1453-1458.